Evidence map›Paper›PMID 19126755›Full record

ReviewPhysiological reviews2009

Mammalian nicotinic acetylcholine receptors: from structure to function.

Edson X Albuquerque, Edna F R Pereira, Manickavasagom Alkondon, Scott W Rogers

Abstract readReview
In one paragraph

Review in Physiological reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 856 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
856citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

856 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

796 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edson X AlbuquerqueDepartment of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, MD, USA.
Edna F R Pereira
Manickavasagom Alkondon
Scott W Rogers

Funding

Nicotine Abuse /Smoking-Related Disease SusceptibilityP01HL072903 · NHLBI · UNIVERSITY OF UTAH · PI METHERALL, JAMES E · 2002 to 2006
$11.1M
Nicotinic receptors: Role in hippocampal synaptic functionR01NS025296 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI ALBUQUERQUE, EDSON X · 1987 to 2012
$3.9M
Age and sex effects on nerve agent damage to the brain and antidotal therapiesU01NS059344 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI ALBUQUERQUE, EDSON X · 2006 to 2010
$3.7M
Nicotinic Receptors and COX2 in the Aging BrainR01AG017517 · NIA · UNIVERSITY OF UTAH · PI ROGERS, SCOTT WARREN · 2001 to 2011
$1.9M
NHLBI NIH HHS P01 HL072903NHLBI NIH HHS P01-HL-72903NIA NIH HHS AG-17517NIA NIH HHS R01 AG017517NINDS NIH HHS NS-25296NINDS NIH HHS R01 NS025296NINDS NIH HHS U01 NS059344NINDS NIH HHS U01-NS-59344
6 · The paper itself

Abstract

The classical studies of nicotine by Langley at the turn of the 20th century introduced the concept of a "receptive substance," from which the idea of a "receptor" came to light. Subsequent studies aided by the Torpedo electric organ, a rich source of muscle-type nicotinic receptors (nAChRs), and the discovery of alpha-bungarotoxin, a snake toxin that binds pseudo-irreversibly to the muscle nAChR, resulted in the muscle nAChR being the best characterized ligand-gated ion channel hitherto. With the advancement of functional and genetic studies in the late 1980s, the existence of nAChRs in the mammalian brain was confirmed and the realization that the numerous nAChR subtypes contribute to the psychoactive properties of nicotine and other drugs of abuse and to the neuropathology of various diseases, including Alzheimer's, Parkinson's, and schizophrenia, has since emerged. This review provides a comprehensive overview of these findings and the more recent revelations of the impact that the rich diversity in function and expression of this receptor family has on neuronal and nonneuronal cells throughout the body. Despite these numerous developments, our understanding of the contributions of specific neuronal nAChR subtypes to the many facets of physiology throughout the body remains in its infancy.

Indexed as

Alzheimer DiseaseAnimalsBrainDisease Models, AnimalGene Expression RegulationHumansParkinson DiseaseReceptors, NicotinicReceptors, Nicotinic

Identifiers

PMID19126755
PMCPMC2713585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.